Skip to content

Validation of Presence-IP1.0 for Detection of Consciousness Using Reduced-Montage TMS-EEG

Prospective Validation of a Reduced-Montage TMS-EEG Complexity Algorithm (Presence-IP1.0) to Differentiate Conscious and Unconscious States Across Wakefulness and Sleep

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07523191
Enrollment
30
Registered
2026-04-13
Start date
2026-03-18
Completion date
2027-05-01
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep

Keywords

TMS-EEG, consciousness, complexity

Brief summary

This study aims to validate a novel real-time algorithm (Presence-IP1.0) designed to detect consciousness from TMS-evoked EEG responses using a reduced electrode montage. Thirty healthy adult participants will undergo TMS-EEG recordings during wakefulness and sleep. The algorithm's ability to differentiate conscious from unconscious states will be evaluated against behavioral and physiological state classification. The goal is to determine whether Presence-IP1.0 achieves clinically useful accuracy for detecting consciousness using a portable, reduced-channel system.

Interventions

DEVICETMS combined with EEG

Structural MRI is used to help determine coil placement, before TMS-EEG visit.

DEVICEPresence-IP1.0

novel algorithm

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER
National Institute of Neurological Disorders and Stroke (NINDS)
CollaboratorNIH
Intrinsic Powers, Inc
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults greater than or equal to 18 years * Able to provide informed consent * Able to undergo TMS and EEG recordings * Able to sleep in laboratory setting

Exclusion criteria

* History of neurological or psychiatric disorders * Pregnancy * Sleep disorders affecting normal sleep architecture * Current history of poorly controlled headaches including intractable or poorly controlled migraines * Any systemic illness or unstable medical condition that may cause a medical emergency in case of a provoked seizure (cardiac malformation, cardiac dysrhythmia, asthma, etc.) * Possible pregnancy or plan to become pregnant in the next 6 months * Any metal in the head * Any metal in the body * Any medical devices or implants (i.e. cardiac pacemaker, medication infusion pump, cochlear implant, vagal nerve stimulator) unless otherwise approved by the responsible MD * Dental implants * Permanent retainers * Claustrophobia (a fear of small or closed places) * Back problems that would prevent lying flat for several hours * Regular night-shift work (second or third shift)

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of Presence-IP1.0 to classify consciousness state (AUC)data collected during experimental sessions (2 visits, up to 8 hours each)Area under the receiver operating characteristic curve (AUC) for discriminating conscious versus unconscious states using Presence-IP1.0

Secondary

MeasureTime frameDescription
Sensitivity of Presence-IP1.0data collected during experimental sessions (2 visits, up to 8 hours each)Sensitivity will refer to TP/(TP+FN) Where TP is Presence-IP1.0 correctly diagnosing consciousness and FN is Presence-IP1.0 falsely diagnosing unconsciousness.
Specificity of Presence-IP1.0data collected during experimental sessions (2 visits, up to 8 hours each)Specificity is TN/(TN+FP) Where TN is Presence-IP1.0 correctly diagnosing unconsciousness and FP is Presence-IP1.0 falsely diagnosing consciousness.
Signal to Noise Ratiodata collected during experimental sessions (2 visits, up to 8 hours each)To assess the signal quality of reduced EEG montage, the signal-to-noise ratio will be reported.
Stability of TMS-evoked responsesdata collected during experimental sessions (2 visits, up to 8 hours each)To assess the signal quality of reduced EEG montage, the stability of TMS-evoked responses will be reported. This refers to the reproducibility of the TMS response components across the first vs the second half of stimulation runs.
Agreement with standard high-density EEG metrics (if availabledata collected during experimental sessions (2 visits, up to 8 hours each)Comparison of average performance of PresenceIP1.0 on the lower-density EEG dataset acquired to this study compared to a reference, previously acquired high-density EEG dataset.

Countries

United States

Contacts

CONTACTMelanie Boly, MD, PhD
boly@neurology.wisc.edu608-263-4338
CONTACTUrszula Gorska, PhD
gorska@wisc.edu
PRINCIPAL_INVESTIGATORMelanie Boly, MD, PhD

UW School of Medicine and Public Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026